Published in Exp Biol Med (Maywood) on April 20, 2016
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46
Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med (2005) 4.32
Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem (1996) 3.57
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A (1990) 2.28
Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res (2002) 1.79
Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci (2008) 1.76
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes (2012) 1.36
Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem (1996) 1.34
Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes (2007) 1.29
Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care (2005) 1.26
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet (2010) 1.15
Concomitant macro and microvascular complications in diabetic nephropathy. Saudi J Kidney Dis Transpl (2009) 1.07
Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest (1996) 1.02
Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care (2008) 1.02
Novel role of erythropoietin in proliferative diabetic retinopathy. Diabetes Res Clin Pract (2007) 0.99
Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Invest (1995) 0.94
The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Hum Genet (2014) 0.93
Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol (2011) 0.91
Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol (2010) 0.90
Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol (2006) 0.87
Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--3. Diabetes Technol Ther (2014) 0.86
Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population. J Epidemiol (2013) 0.85
Association of erythropoietin gene polymorphisms with retinopathy in a Chinese cohort with type 2 diabetes mellitus. Clin Experiment Ophthalmol (2015) 0.81